 |
Christopher Haqq, MD, PhD
Recent Publications |
Publications – 2009 |
 |
Torabian, S.Z., D. de Semir, M. Nosrati, S. Bagheri, A.A. Dar, S. Fong, Y. Liu, S. Federman, J. Simko, C. Haqq, R.J. Debs, and M. Kashani-Sabet, Ribozyme-Mediated Targeting of IΚBΓ Inhibits Melanoma Invasion and Metastasis. Am J Pathol, 2009. |
| |
Publications – 2008 |
|
Ornish, D., M.J. Magbanua, G. Weidner,
V. Weinberg, C. Kemp, C. Green, M.D. Mattie, R. Marlin, J.
Simko, K. Shinohara, C.M. Haqq, and P.R. Carroll, Changes
in prostate gene expression in men undergoing an intensive
nutrition and lifestyle intervention. Proc Natl Acad Sci
U S A, 2008. 105(24): p. 8369-74. |
|
Rangel, J., M. Nosrati, S.P. Leong, C.
Haqq, J.R. Miller, 3rd, R.W. Sagebiel, and M. Kashani-Sabet,
Novel role for RGS1 in melanoma progression. Am J Surg Pathol,
2008. 32(8): p. 1207-12. |
|
Rangel, J., M. Nosrati, S. Torabian,
L. Shaikh, S.P. Leong, C. Haqq, J.R. Miller, 3rd, R.W. Sagebiel,
and M. Kashani-Sabet, Osteopontin as a molecular prognostic
marker for melanoma. Cancer, 2008. 112(1): p. 144-50. |
| |
Publications – 2007 |
|
Bolton, E.C., A.Y. So, C. Chaivorapol,
C.M. Haqq, H. Li, and K.R. Yamamoto, Cell- and gene-specific
regulation of primary target genes by the androgen receptor.
Genes Dev, 2007. 21(16): p. 2005-17. |
|
Rubenstein, J.L., J. Fridlyand, L. Abrey, A. Shen, J.
Karch, E. Wang, S. Issa, L. Damon, M. Prados, M. McDermott,
J. O'Brien, C. Haqq, and M. Shuman, Phase I study of intraventricular
administration of rituximab in patients with recurrent
CNS and intraocular lymphoma. J Clin Oncol, 2007. 25(11):
p. 1350-6.
|
|
Ryan, C.J., C.M. Haqq, J. Simko, D.F. Nonaka, J.M. Chan,
V. Weinberg, E.J. Small, and I.D. Goldfine, Expression
of insulin-like growth factor-1 receptor in local and metastatic
prostate cancer. Urol Oncol, 2007. 25(2): p. 134-40. |
| |
return
to top
|
|
|
|
|
|
